A team of French researchers has come up with an anti-Covid solution which is an alternative to a vaccination and which could be ready for use in the form of a nasal spray. They have created a peptide, made up of natural amino acids which lures the virus to it by mimicking the ACE2 lock, and so prevents it from entering into human cells. They have tested it on pulmonary cells and found it has worked without any toxic reaction to humans. These first-in-class blocking peptide mimics represent powerful tools that might be used in prophylactic and therapeutic approaches to fight the coronavirus disease 2019.
Two experimental DNA vaccines to prevent Ebola virus and the closely related Marburg virus are safe, and generated a similar immune response in healthy Ugandan adults as reported in healthy US adults earlier this year. The findings are from the first trial of filovirus vaccines in Africa.
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke.
BigField GEG Tech's insight:
AstraZeneca shares turned negative Wednesday after a Brazilian health authority said a volunteer in its coronavirus vaccine study died.
The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
A team of French researchers has come up with an anti-Covid solution which is an alternative to a vaccination and which could be ready for use in the form of a nasal spray. They have created a peptide, made up of natural amino acids which lures the virus to it by mimicking the ACE2 lock, and so prevents it from entering into human cells. They have tested it on pulmonary cells and found it has worked without any toxic reaction to humans. These first-in-class blocking peptide mimics represent powerful tools that might be used in prophylactic and therapeutic approaches to fight the coronavirus disease 2019.